Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have discovered a ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Oncology nurses can help patients understand this novel mechanism of action and its potential as a treatment option.

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for chemotherapy in certain patients with NSCLC.

Help is now there for those diagnosed with hard-to-treat blood cancers like leukemia and lymphoma, as new therapies are available to bolster the immune system by using novel engineered antibodies that ...

FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.

A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for ...

ELIAS Cancer Immunotherapy was combined with chemotherapy in a study with results presented at the 2025 ACVIM Forum ...

(UroToday.com) The Interdisciplinary Genitourinary Cancer Forum 2025, held between June 19 – 21, 2025 held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 6: ...

When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies ...

Therapy is one of the most revolutionary advancements in oncology, offering a personalized immunotherapy approach that reprograms a patient’s T-cells to recognize and attack cancer cells. This cutting ...